<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE298nnn/GSE298937/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Rattus norvegicus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298937</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Changes in RNA expression underlying sustained antidepressant effects</name><description>We performed RNA-seq profiling of the medial prefrontal cortex (mPFC) in Wistar Kyoto (WKY) rats, an animal model of treatment-resistant depression. The WKY rats were treated for 7 days with either K-4, a novel positive allosteric modulator of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), or racemic ketamine. After a 7-day drug withdrawal period, mPFC tissues were collected and subjected to RNA-seq analysis. This study contributes to a understanding of the molecular mechanisms underlying the sustained antidepressant effects of ketamine.</description><dates><publication>2026/06/04</publication></dates><accession>GSE298937</accession><cross_references><GSM>GSM9026248</GSM><GSM>GSM9026249</GSM><GSM>GSM9026246</GSM><GSM>GSM9026247</GSM><GSM>GSM9026253</GSM><GSM>GSM9026254</GSM><GSM>GSM9026251</GSM><GSM>GSM9026252</GSM><GSM>GSM9026250</GSM><GPL>25947</GPL><GSE>298937</GSE><taxon>Rattus norvegicus</taxon></cross_references></HashMap>